spacer
spacer

PDBsum entry 4poc

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Isomerase PDB id
4poc

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
246 a.a.
Ligands
PO4
Metals
_BR ×2
__K ×2
_NA
Waters ×327
PDB id:
4poc
Name: Isomerase
Title: Structure of triosephosphate isomerase wild type human enzyme.
Structure: Triosephosphate isomerase. Chain: a, b. Synonym: tim, triose-phosphate isomerase. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: tpi, tpi1. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
1.60Å     R-factor:   0.155     R-free:   0.187
Authors: C.G.Amrich,A.A.Aslam,A.Heroux,A.P.Vandemark
Key ref: B.P.Roland et al. (2015). Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiency. Biochim Biophys Acta, 1852, 61-69. PubMed id: 25463631 DOI: 10.1016/j.bbadis.2014.10.010
Date:
25-Feb-14     Release date:   14-Jan-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P60174  (TPIS_HUMAN) -  Triosephosphate isomerase from Homo sapiens
Seq:
Struc:
249 a.a.
246 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 2: E.C.4.2.3.3  - methylglyoxal synthase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: dihydroxyacetone phosphate = methylglyoxal + phosphate
dihydroxyacetone phosphate
= methylglyoxal
+
phosphate
Bound ligand (Het Group name = PO4)
corresponds exactly
   Enzyme class 3: E.C.5.3.1.1  - triose-phosphate isomerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: D-glyceraldehyde 3-phosphate = dihydroxyacetone phosphate
D-glyceraldehyde 3-phosphate
Bound ligand (Het Group name = PO4)
matches with 50.00% similarity
= dihydroxyacetone phosphate
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/j.bbadis.2014.10.010 Biochim Biophys Acta 1852:61-69 (2015)
PubMed id: 25463631  
 
 
Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiency.
B.P.Roland, C.G.Amrich, C.J.Kammerer, K.A.Stuchul, S.B.Larsen, S.Rode, A.A.Aslam, A.Heroux, R.Wetzel, A.P.VanDemark, M.J.Palladino.
 
  ABSTRACT  
 
Triosephosphate isomerase (TPI) is a glycolytic enzyme which homodimerizes for full catalytic activity. Mutations of the TPI gene elicit a disease known as TPI Deficiency, a glycolytic enzymopathy noted for its unique severity of neurological symptoms. Evidence suggests that TPI Deficiency pathogenesis may be due to conformational changes of the protein, likely affecting dimerization and protein stability. In this report, we genetically and physically characterize a human disease-associated TPI mutation caused by an I170V substitution. Human TPI(I170V) elicits behavioral abnormalities in Drosophila. An examination of hTPI(I170V) enzyme kinetics revealed this substitution reduced catalytic turnover, while assessments of thermal stability demonstrated an increase in enzyme stability. The crystal structure of the homodimeric I170V mutant reveals changes in the geometry of critical residues within the catalytic pocket. Collectively these data reveal new observations of the structural and kinetic determinants of TPI Deficiency pathology, providing new insights into disease pathogenesis.
 

 

spacer

spacer